PAX8 and nonpapillary renal cell carcinoma: The requirement of both PAX8 and HIF2A for E11:69419 activity and the strong association of rs7948643 with ccRCC, but not papillary RCC, support a model in which the difference in PAX8 binding at rs7948643 is the cause of increased ccRCC risk associated with this locus.